Pharmaceutical Glass Tubing Market

Pharmaceutical Glass Tubing Market Overview:

According to Reports and Insights analysis, the global pharmaceutical glass tubing market is estimated to be US$ 1,553.5 Mn in 2022. Furthermore, the pharmaceutical glass tubing market to register a CAGR of 6.1% which is expected to result in market forecast value for 2030 as US$ 2,483.3 Mn.

Pharmaceutical glass tubing is in higher demand as a result of the rise in chronic diseases and the self-injectable syringes used to treat them. As the demand for manufacturing expanded, firms started incorporating artificial intelligence into their procedures, switching from manual to automated procedures in response.

Companies are boosting the manufacturing of environmentally friendly glass tubing that is easily recyclable to increase their production capabilities and assist reduce the quantity of medical waste generated by the pharmaceutical and biotechnology industries.

This market study on the global pharmaceutical glass tubing market aims to cover market dynamics such as market drivers, challenges/restraints, and opportunities for the market players. It will also cover market segmentation outlook, pharmaceutical glass tubing market trend, regional outlook, pharmaceutical glass tubing market size, and market share, as well as industry and product insights, SWOT analysis, Porter's five force analysis, PESTEL analysis, heat map analysis, market forecast, and the major players operating in the pharmaceutical glass tubing market.

Scope of the Report:

Report Metric	Report Details
Market size available for the years	2022-2030
Base year	2021
Forecast Period	2022-2030
Segments Covered	By Material Type, By Neck Diameter, By Parenteral End Use, and By Region
Regions Covered	North America, Latin America, Asia Pacific, Europe, Middle East and Africa
Key Players	Schott AG, Nipro Pharma Corporation, Corning Incorporated, Nippon Electric Glass Co., Ltd., Accu-Glass LLC., Richland Glass Co., Inc., Cang Zhou Four-star Glass Co., Ltd., LINUO Group, DWK Life Sciences GmbH, Puyang New Harmony Industrial Development Co., LTD, Shandong Pharmaceutical Glass Co, Ltd.

Pharmaceutical Glass Tubing Market Drivers: pharmaceutical industry's increased demand for sterile medical packaging goods

The market is expanding due to the constantly expanding global pharmaceutical sector. Pharmaceutical glass tubing is more in demand now than ever before because of the rise in chronic diseases and the use of self-injectable syringes to treat them. Additionally, a rise in government expenditures on R&D as well as technological developments in the glass container industry may support the expansion of this market. The market for pharmaceutical glass tubing will expand during the projected period as a result of escalating spending on OTC and prescription medications. Additionally, the usage of glass in pharmaceutical packaging products has expanded due to the establishment of strict rules to enhance the quality and integrity of medications produced domestically. 

Because of government incentives, the pharmaceutical industry is growing in India. Identified essential starting materials, drug intermediates, and active pharmaceutical components were covered in the curriculum. India has some of the lowest manufacturing expenses worldwide. Compared to them and almost all of Europe, it is calmer. To combat the epidemic, major pharmaceutical companies are spending. Large pharmaceutical firms have made major expenditures, which are fueling the industry's growth and the demand for packaging.

Pharmaceutical Glass Tubing Market Restraints: Higher Relevance of Alternative Sources

In the pharmaceutical glass packaging market, glass delamination is the main issue that has been identified, and it may eventually cause some demand reduction.

The preferred materials for pharmaceutical packaging have always been aluminum and glass. Owing to increase raw material prices and other factors, these materials eventually proved unaffordable. They were unable to offer options for mass-produced goods that were commercially viable in terms of packaging. After that, the possibility of plastics began to materialize. PET is beginning to supplant glass as the preferred packaging material for solid oral pharmaceuticals. For liquid formulas, glass remains the most used medium. Collapsible tubes made of aluminum and plastic are preferred for semi-solid compositions, nevertheless. Any material used for pharmaceutical packaging must pass a stringent inspection to be approved as a package, according to ICH (WHO) standards.

Pharmaceutical Glass Tubing Market Opportunities: Excellent Recyclability

Due to its chemical resistance, glass can survive a wide range of chemical mixtures. Borosilicate tube glass is crucial in pharmaceutical applications for storing chemicals and drugs due to its chemical inertness and capacity to preserve its original form in typical environmental conditions. Due to glass's capacity for recycling, its fast-increasing commodity value is what is driving the demand for glass tubing.

Pharmaceutical Glass Tubing Market, by Material Type:

Based on the material type, the global pharmaceutical glass tubing market is segmented into; Type I (Borosilicate Neutral Glass mainly used for packaging of aqueous solutions), Type II (Surface Treated Borosilicate Glass mainly used for packaging of acidic solution), Type III (Soda Lime Glass mainly used for packaging of oral solid dosages such as tablets and capsules).

Pharmaceutical Glass Tubing Market, by Neck Diameter:

Based on the neck diameter, the global pharmaceutical glass tubing market is segmented into; Up to 40 mm, 40 mm to 80 mm, 80 mm to 120 mm, and More than 120 mm.

Pharmaceutical Glass Tubing Market, by Parental End Use:

Based on the parenteral end use, the global pharmaceutical glass tubing market is segmented into; ampoules, bottles, cartridges, syringes, and vials.

Pharmaceutical Glass Tubing Market, by Region:

Due to the substantial presence of pharmaceutical businesses and tubing producers in these regions, North America and Europe dominate the market for pharmaceutical glass tubing.

Businesses like Schott, Nipro, and others command a large portion of the market and have a monopoly. It has been noted that the sales revenue of these businesses has expanded at a commendable rate in recent years, which represents a strong market expansion.

The third-largest market share for pharmaceutical glass tubing is held by the Asia-Pacific region. Famous firms are also refocusing their efforts to invest in emerging markets considerably increase their market share in such areas. The markets for pharmaceutical glass tubing in MEA and Japan also have scope for expansion.

Pharmaceutical Glass Tubing Market Contemporary Developments:

In 2022 September-With spending tens of millions of euros, China and Hungary will be able to produce significantly more pharmaceutical cartridges. Drugs like insulin, GLP-1, or growth hormones that can be administered by self-injection using an auto-injector are kept and administered in cartridges. SCHOTT Pharma sells cartridges that may be inserted into a variety of machines and deliver safe, simple drug delivery in remarkably precise amounts. Modern shaping technology and online inspection tools will be developed by the company with the help of funding.